CAMEO+ eventCORPORATE2026-04-09馃嚝馃嚪
Kainova expands DT 7012 clinical trial into Europe
source: Kainova Therapeutics
On 2026-04-09, Kainova Therapeutics dosed the first patient in the European expansion of its DOMISOL phase 1/2 trial of DT 7012. The trial is enrolling patients at oncology centres in France, including H么pitaux Universitaires de Strasbourg, Institut Gustave Roussy in Paris, and Institut Bergoni茅 Bordeaux.
0.11Significance1.0Magnitude0.1Systemic0.1Market1Articles
Location
FranceEuropeFranceEurope46.228, 2.214
Story Links